It is the first clinical study to test if aspirin can make tumours more sensitive to immunotherapy drugs in triple negative breast cancer. It is a less common but often more aggressive type of breast cancer that disproportionately affects younger women and black women. WHAT IS TRIPLE NEGATIVE BREAST CANCER? Triple negative breast cancer makes up around 10-to-20 per cent of all forms of the disease. Some immunotherapies are already used in secondary triple negative breast cancer treatment, but they do not work for everyone.

Source: Daily Mail August 17, 2021 23:55 UTC